Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase

International Immunology
A L MellorD H Munn

Abstract

Murine dendritic cells (DCs) expressing indoleamine 2,3 dioxygenase (IDO) catabolize tryptophan and can suppress T cell responses elicited in vivo. Here, we identify specific subsets of splenic (CD11c+) dendritic cells competent to mediate IDO-dependent T cell suppression following CTLA4-mediated ligation of B7 molecules. IDO-competent DC subsets acquired potent and dominant T cell suppressive properties as a consequence of IDO up-regulation, as they blocked the ability of T cells to respond to other stimulatory DCs in the same cultures. Soluble CTLA4 (CTLA4-Ig) and cloned CTLA4+ regulatory T cells (Tr1D1) up-regulated IDO selectively in DC subsets co-expressing B220 or CD8alpha. The ability of Tr1D1 T cells to suppress CD8+ T cell responses was completely dependent on their ability to induce tryptophan catabolism in DCs. Selective IDO up-regulation in DCs did not inhibit T cell activation, but prevented T cell clonal expansion due to rapid death of activated T cells. T cell responses were restored by genetic or pharmacologic inhibition of IDO enzyme activity, or by adding excess tryptophan. DCs from interferon gamma (IFNgamma)-receptor-deficient mice were effective in promoting IDO-dependent T cell suppression following CTLA4-...Continue Reading

Citations

Dec 30, 2011·Cellular and Molecular Life Sciences : CMLS·David M Gravano, Dario A A Vignali
Jun 28, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Erik Kwidzinski, Ingo Bechmann
Sep 19, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Alexey Popov, Joachim L Schultze
Mar 31, 2012·Analytical and Bioanalytical Chemistry·Hidetsugu FujigakiKuniaki Saito
Dec 8, 2007·Langenbeck's Archives of Surgery·Stefan Löb, Alfred Königsrainer
Sep 9, 2008·Journal of Clinical Immunology·Herman WaldmannStephen Cobbold
Apr 14, 2011·Journal of Clinical Immunology·Crisol Álvarez-QuirogaRoberto González-Amaro
Nov 2, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Carol A Colton
Aug 7, 2008·Current Allergy and Asthma Reports·Carlos J SuarezPatricia W Finn
Nov 23, 2011·Immunologic Research·Tahereh KalantariAbdolmohamad Rostami
Dec 23, 2008·Eye·K A WilliamsD J Coster
Jul 19, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lisa O'FlynnThomas Ritter
Mar 5, 2008·Nature Clinical Practice. Gastroenterology & Hepatology·Bertus Eksteen, James M Neuberger
Oct 22, 2004·Nature Immunology·Eric C Logue, William C Sha
Jul 25, 2006·Nature Reviews. Cancer·Alexander J Muller, Peggy A Scherle
Dec 15, 2012·Nature Reviews. Drug Discovery·László VécseiJózsef Toldi
Oct 22, 2005·Nature Reviews. Immunology·Casey J FoxCraig B Thompson
Jul 14, 2007·Nature Reviews. Immunology·Adrian E Morelli, Angus W Thomson
Nov 26, 2011·Nature Reviews. Immunology·Lucy S K Walker, David M Sansom
Oct 9, 2013·Nature Reviews. Nephrology·Mandy L FordThomas C Pearson
Oct 28, 2008·Proceedings of the National Academy of Sciences of the United States of America·Alexander J MullerAndrew L Mellor
Jul 2, 2009·Proceedings of the National Academy of Sciences of the United States of America·Stephen P CobboldHerman Waldmann
May 26, 2010·Proceedings of the National Academy of Sciences of the United States of America·Burles A JohnsonAndrew L Mellor
Apr 27, 2012·The Journal of Biological Chemistry·Manuela SchmidNishith Gupta
Jun 12, 2013·The Journal of Experimental Medicine·Rikke B HolmgaardJames P Allison
Apr 5, 2012·The Journal of Infectious Diseases·Jennifer A Loughman, David A Hunstad
Dec 7, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jenna M Benson, David M Shepherd
Sep 29, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jenna M Benson, David M Shepherd
Oct 12, 2011·Current Opinion in Allergy and Clinical Immunology·James W Verbsky, Talal A Chatila
Jan 1, 2013·Current Opinion in Rheumatology·Gerdien MijnheerFemke van Wijk
Sep 9, 2005·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Stephen P Cobbold
Apr 17, 2012·Journal of Biomedicine & Biotechnology·Fabian BenenciaMaria Muccioli
Feb 9, 2012·Clinical & Developmental Immunology·Theodore S JohnsonBernard L Maria
Feb 2, 2010·American Journal of Respiratory Cell and Molecular Biology·Sara A PaveglioMatthew E Poynter
Mar 20, 2009·Journal of the American Society of Nephrology : JASN·Yanfei HuangKarl L Womer
Dec 1, 2006·Annual Review of Immunology·Gabriel A RabinovichEduardo M Sotomayor
Aug 19, 2006·Immunological Investigations·Ingo Fricke, Dmitry I Gabrilovich

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.